Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: CytomX Therapeutics (CTMX), AbCellera Biologics (ABCL)

Tipranks - Tipranks - Fri Nov 7, 2025

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CytomX Therapeutics (CTMX – Research Report) and AbCellera Biologics (ABCL – Research Report) with bullish sentiments.

Meet Your ETF AI Analyst

CytomX Therapeutics (CTMX)

In a report released yesterday, Matthew Biegler from Oppenheimer reiterated a Buy rating on CytomX Therapeutics, with a price target of $7.00. The company’s shares closed last Thursday at $4.19.

According to TipRanks.com, Biegler has 0 stars on 0-5 stars ranking scale with an average return of -4.2% and a 39.0% success rate. Biegler covers the Healthcare sector, focusing on stocks such as BridgeBio Oncology Therapeutics, Acrivon Therapeutics, Inc., and Day One Biopharmaceuticals. ;'>

Currently, the analyst consensus on CytomX Therapeutics is a Strong Buy with an average price target of $5.50.

See the top stocks recommended by analysts >>

AbCellera Biologics (ABCL)

TD Cowen analyst Brendan Smith maintained a Buy rating on AbCellera Biologics today. The company’s shares closed last Thursday at $4.53, close to its 52-week high of $4.75.

According to TipRanks.com, Smith is a 4-star analyst with an average return of 12.5% and a 57.1% success rate. Smith covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Recursion Pharmaceuticals, and Ginkgo Bioworks Holdings. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for AbCellera Biologics with a $8.00 average price target.

Read More on CTMX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).